Format

Send to

Choose Destination
Evid Based Med. 2016 Dec;21(6):224. doi: 10.1136/ebmed-2016-110562. Epub 2016 Oct 18.

Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes.

Author information

1
Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
2
Division of Endocrinology, University Hospital 'Dr. Jose E. Gonzalez' Autonomous University of Nuevo Leon, Monterrey, Mexico.
3
Knowledge and Evaluation Research Unit and Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.
PMID:
27884884
DOI:
10.1136/ebmed-2016-110562
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center